At-Risk Diabetes Patients Could Get Drug Before January

The Food and Drug Administration’s potential breakthrough drug for diabetes – which has the capacity to delay the onset of Type 1 diabetes — could be ready for high-risk patients before January.According to The New York Times, Tzield (or teplizumab) became the result of an…